Multiple Myeloma

AQUILA, COBRA, TecLILLE, and MajesTEC-3 Trials Signal Shifts in Myeloma Management

Ben Derman, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Collaboration is Key to Safely Transition Care in MM Following Cellular Therapy

Hamza Hashmi, MD, Shreyas Kalantri, MD

Early Intervention Strategies in High-Risk Smoldering Multiple Myeloma

Anuja V. Abhyankar, MD, Jing Wang, MD

How to Select Treatment in Relapsed Multiple Myeloma

Anuja V. Abhyankar, MD, S. Vincent Rajkumar, MD

Bispecific Antibodies and CAR T Redefine Early-Line Treatment in Multiple Myeloma

Robert Orlowski, MD, PhD, Hamza Hashmi, MD

Pretransplant Functional Status as a Predictor of Outcomes in Multiple Myeloma

Sawyer Bawek, DO, Rahul Gosain, MD, MBA